Strand Life Sciences

MaatriSeq is a Non-Invasive Prenatal Screening (NIPS) test that is a cell-free DNA-based screening method used to detect chromosomal abnormalities in the fetus during pregnancy, validated specifically on Indian samples and conditions.

A cell-free DNA-based screening method used to detect chromosomal abnormalities in the fetus during pregnancy, screening for six common microdeletions and duplications along with autosomal and sex chromosomal aneuploidies.

NGS panel analyzing 20 genes for disorders such as Menkes disease, Wilson disease, Hypomagnesemia, Hemochromatosis, and Gitelman syndrome.

NGS panel analyzing 25 genes for conditions such as Smith-Lemli-Opitz syndrome and Progressive familial intrahepatic cholestasis.

CNSeqHD is a higher resolution NGS-based chromosomal analysis technique to detect aneuploidies of all chromosomes and copy number variations (~50kb resolution), enabling a more comprehensive grasp of structural variations in the genome with unbiased CNV calling.

An advanced NGS-based alternative for chromosomal microarray analysis that provides superior accuracy in detecting Copy Number Variants (CNVs) and aneuploidies across the genome with a resolution of 500 Kb.

A cutting-edge, robust early warning test that works off a simple blood draw and uses proprietary genome sequencing and analysis to identify DNA methylation signatures of cancer in the blood.

An automated tertiary analysis software solution for reporting variants from oncology NGS panels, delivering clinical reports within 1-2 minutes.

StrandOmics is a proprietary clinical genomics interpretation and reporting platform for germline variant curation, tertiary analysis, and clinical report generation.

Strand ORION is Strand's AI-powered germline interpretation and reporting suite, integrating StrandNGS, StrandOMS, StrandOmics, FestiVAR, autoMeta, Blitz and Siachen into a unified workflow from variant calling through clinical reporting.

festiVAR (Fast Estimation of Variants for Automated Reporting) is an AI-powered variant prioritization engine designed to accelerate germline variant interpretation from whole exome and genome sequencing data.

HIPAA-compliant platform for variant classification and interpretation, powering NGS tertiary analysis.

Clinical Exome Sequencing (CES) is a targeted genetic analysis technique that can analyze approximately 6,500 genes associated with a wide range of well-defined genetic disorders.

Bioinformatics platform for Genomics, Transcriptomics, and Customized Bioinformatics supporting agricultural data pipelines and multi-omics analysis.

Strand NGS is a comprehensive platform designed for the analysis of NGS data, providing advanced informatics capabilities, variant mapping and annotation, and reporting.

An AI-assisted workflow and software solution utilizing large language models to accelerate germline variant interpretation, clinical notes to HPO conversion, gene scoring, and ACMG labeling.

ExomePlus is a comprehensive high-throughput exome sequencing test performed on the NovaSeq X Plus with an average sequencing depth of >100X, enabling superior SNV and CNV detection.

Blitz is an AI-powered literature intelligence engine that accelerates germline variant interpretation by automating literature retrieval, evidence extraction, and ACMG evidence assessment.

Whole Exome Sequencing (WES) offers a comprehensive view of exonic regions of the genome allowing the detection of a wide range of genetic variants.

Whole Exome Trio analysis enables the simultaneous examination of approximately 20,000 genes to detect genetic changes such as Single Nucleotide Variants, Insertions or Deletions, and Copy number variations by sequencing a family trio.

Rasopathies testing panel analyzing 15 genes.

Osteogenesis imperfecta (OI) and decreased bone density testing panel analyzing 30 genes.

Dysostosis testing panel analyzing 97 genes.

Osteopetrosis and related disorder testing panel analyzing 15 genes.

Defects in joint formation & synostoses testing panel analyzing 57 genes.

Polydactyly-syndactyly-triphalangism testing panel analyzing 31 genes.

Ciliopathies with major skeletal involvement testing panel analyzing 46 genes.

Ectrodactyly with/without other manifestations testing panel analyzing 8 genes.

Limb hypoplasia-reduction defects testing panel analyzing 60 genes.

NGS panel analyzing 63 genes for conditions such as Mucopolysaccharidosis, Gangliosidosis, Niemann-Pick disease, and Gaucher disease.

Genetic test analyzing 161 genes associated with microcephaly, such as Aicardi-Goutières syndrome, Coffin-Siris syndrome, Cornelia de Lange syndrome, and Seckel syndrome.

NGS panel analyzing 55 genes involved in congenital disorders of glycosylation.

Genetic test analyzing 139 genes associated with brain malformations such as agenesis of the corpus callosum, Dandy-Walker syndrome, Holoprosencephaly, Hydrocephalus, Lissencephaly, Meckel syndrome, Polymicrogyria, and Pontocerebellar hypoplasia.

Overgrowth syndromes with skeletal involvement testing panel analyzing 19 genes.

Skeletal dysplasia testing panel analyzing 159 genes.

Genetic test analyzing 97 genes associated with epilepsy, including epileptic encephalopathy, infantile spasm (West syndrome), Lennox-Gastaut syndrome, and neuronal ceroid lipofuscinosis.

Abnormal mineralization disorders testing panel analyzing 25 genes.

NGS panel analyzing 32 genes for conditions such as Adenylosuccinase deficiency and Dihydropyrimidine dehydrogenase deficiency.

NGS panel analyzing 42 genes for conditions such as Sickle cell anemia, beta-Thalassemia, Diamond-Blackfan anemia, Porphyrias, and Spherocytosis.

Genetic test analyzing 83 genes associated with macrocephaly.

NGS panel analyzing 70 genes for disorders such as Glycogen Storage Disorders, Galactosemia, Hereditary Fructose intolerance, and Pyruvate carboxylase deficiency.

NGS panel analyzing 46 genes for conditions such as Fatty acid oxidation disorders, Zellweger Syndrome Spectrum, and Carnitine deficiency.

The Somatic Advantage 500 Standard (SA500 Standard) leverages advanced NGS technology to analyze a broad range of mutations across 500+ genes in tumor samples, covering DNA and RNA analysis along with Tumor Mutation Burden (TMB) and Microsatellite Instability (MSI).

NGS panel analyzing 104 genes for disorders such as Maple syrup urine disease, urea cycle disorders, organic acidurias, phenylketonuria, and homocystinuria.

Intellectual disability genetic testing panel analyzing 199 genes.

Osteolysis related disorders testing panel analyzing 20 genes.

Genetic inflammatory /rheumatoid-like osteoarthropathy testing panel analyzing 25 genes.

NGS panel analyzing 53 genes for conditions such as Inherited hypercholesterolemia, Hypertriglyceridemia, Hyperlipidemias, Alagille syndrome, and Adrenal hyperplasia.

Autism spectrum disorders genetic testing panel analyzing 50 genes.

NGS panel analyzing 24 genes for conditions such as GABA-transaminase deficiency and Segawa syndrome.

Congenital myasthenic syndrome genetic test panel covering 19 genes.

NGS panel analyzing 39 genes for conditions such as Megaloblastic anemia and Molybdenum cofactor deficiency.

Genetic panels targeting genes associated with a range of mitochondrial disorders affecting energy production, fatty acid metabolism, membrane transport, iron-sulfur cluster biogenesis, and creatinine metabolism using NGS technology.

Spastic paraplegia genetic test panel covering 55 genes.

Genetic test targeting 4 genes associated with Alport syndrome.

An epigenetic DNA methylation sequencing service using NGS or long-read technology to identify methylation sites, global and local patterns, and support the development of AI/ML models based on methylation signatures.

Genomic application software developed for Agilent for managing and analyzing omics data and metadata.

This comprehensive test evaluates 36 genes associated with hereditary cancer syndromes across multiple organ systems, including ACMG recommended genes.

Genetic test targeting 10 genes associated with Meckel syndrome.

Genetic test targeting 13 genes associated with Zellweger syndrome.

Genetic test targeting 15 genes associated with Fanconi syndrome including Dent disease and Lowe syndrome.

Genetic test targeting 10 genes associated with atypical hemolytic uremic syndrome.

A unified Docker-based solution that streamlines PacBio tool execution, enabling consistent environments, parallel processing, simplified commands, and consolidated outputs for efficient genomics analysis.

Genetic test targeting 3 genes associated with medullary cystic kidney disease and renal cysts and diabetes syndrome.

Fragile X Triple Repeat Expansion is a genetic test that detects CGG repeat expansions in the FMR1 gene, enabling the identification of Fragile X syndrome.

Multiple ligation-dependent probe amplification (MLPA) analysis can detect if a person suffers from or carries mutations in the dystrophin gene that could cause Duchenne Muscular Dystrophy (DMD).

Genetic test targeting 6 genes associated with Bartter syndrome.

Identifies couples with autosomal recessive/X-linked disease-causing mutations in ~2000 genes to assess risk in pregnancy.

Muscular dystrophy genetic test panel covering 76 genes.

Genetic test targeting 8 genes associated with pseudohypoaldosteronism and Liddle syndrome.

Reporting tool developed for customers of Bio-Rad Laboratories' QXDx BCR-ABL %IS Kit.

Dystonia genetic test panel covering 98 genes.

Genetic test targeting 9 genes associated with focal segmental glomerulosclerosis.

Genetic test targeting 7 genes associated with polycystic kidney disease.

Genetic test targeting 3 genes associated with renal tubular dysgenesis.

This test detects mutations in BRCA1 and BRCA2 genes in tumor tissue for the identification of therapeutic targets.

Neuropathy genetic test panel covering 109 genes.

Genetic test targeting 44 genes associated with various nephropathies including nephronophthisis, nephrotic syndrome, and nephrolithiasis.

This test evaluates mutations in 20 genes associated with hereditary breast and ovarian cancer.

A genetic test for hereditary cancer risks providing clarity on breast or ovarian cancer predispositions.

Cardiomyopathies genetic testing panel covering 79 genes.

An in-house customizable infectious-disease reporting end-to-end solution that processes qPCR input and generates a comprehensive and actionable PDF report with detailed pathogen profiles, antibiotic susceptibility status, and drug recommendations.

This test analyzes the BRCA1, BRCA2, and TP53 genes for mutations associated with hereditary cancer risks.

Myopathy genetic test panel covering 80 genes.

Genetic test targeting 45 genes associated with other renal disorders such as Barakat syndrome and Townes-Brocks Syndrome.

This test screens for mutations in the BRCA1, BRCA2, PALB2, and TP53 genes, which are linked to hereditary breast and ovarian cancer.

Genetic test targeting 2 genes associated with nephrogenic diabetes insipidus.

Genetic test targeting 9 genes associated with ureteral disorders such as Vesicoureteral Reflux.

Preimplantation Genetic Testing for Aneuploidies (PGT-A) is an NGS-based technology used in Assisted Reproductive Technology (ART) procedures to detect chromosomal aneuploidies, including gains and losses across all chromosomes.

Arrhythmias genetic testing panel covering 61 genes.

Genetic test targeting 25 genes associated with renal uricosuria and uricemia disorders such as Cystinosis and Fabry disease.

This test screens for mutations in 16 genes which are associated with hereditary nervous system cancer.

This germline test analyzes 14 genes involved in homologous recombination repair pathways.

Genetic test targeting 3 genes associated with hyperoxaluria.

The Infertility Screening Panel conducts a comprehensive genetic assessment for couples struggling to conceive after a year of attempts.

Genetic test targeting 5 genes associated with renal tubular acidosis.

Comprehensive genetic analysis for a wide spectrum of disorders that can manifest in newborns, examining genes associated with critical areas such as amino acid metabolism, heart function, and endocrine systems.

Karyotyping is a genetic test that analyzes the number and structure of chromosomes in fetal or parental cells, helping detect numerical abnormalities and major structural changes.

A comprehensive DNA analysis revealing health risks and medication response to get a complete picture of your inherited risks.

Genetic test targeting 5 genes associated with renal diseases of glucose handling such as Fanconi-Bickel Syndrome.

AneuXpress Quantitative Fluorescent Polymerase Chain Reaction (QF-PCR) is a highly sensitive DNA-based method for the rapid and accurate detection of common aneuploidies such as trisomy 13, 18, and 12, as well as gonosomal aneuploidy.

Targeted DNA methylation analysis service allowing researchers to investigate methylation patterns at specific DNA regions, genes, or genomic loci using NGS and long-read sequencing.

Warfarin-Clopidogrel drug response genetic testing panel covering 9 genes.

A streamlined diagnostic reporting solution developed by Strand Life Sciences to generate custom PDF reports for molecular testing using a custom template.

Genetic test targeting genes associated with defects in calcium homeostasis such as Hypocalcemia.

Genetic test targeting 8 genes associated with defects in magnesium homeostasis including Gitelman syndrome and Hypomagnesemia.

Genetic test targeting 11 genes associated with defects of renal phosphate handling such as Hypophosphatemia and rickets.

Genetic test targeting 7 genes associated with defects of renal handling of amino acids such as Cystinuria.

A research tool used to measure DNA methylation levels across the genome to study gene expression and its effects on biological processes and diseases.

A genetic test designed to discover what your body really needs for nutrition and fitness to tailor your goals-driven diet plan.

Chemometrics software package for mass spectrometry analysis allowing convenient import of GC/MS and LC/MS data from large sample sets.